Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2005-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.IJROBP.2005.03.007PMID 15927414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

  2004cited by this paper
• A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.

  2004cited by this paper
• Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma

  2004cited by this paper
• Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.

  2004cited by this paper
• Long-term outcome in endometrial carcinoma favors a two- instead of a three-tiered grading system.

  2002cited by this paper
• The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial.

  2001cited by this paper
• Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

  2000cited by this paper
• Revised FIGO staging for gynaecological cancer

  1989cited by this paper

• Avoidance of adjuvant radiotherapy in inter mediate-risk endometrial carcinoma.

  2026cites this paper
• Central Pathology Review of Endometrial Hyperplasia and Adenocarcinoma Before and After Treatment With the Levonorgestrel Intrauterine Device–Results From the feMMe Phase 2 Randomized Clinical Trial

  2025cites this paper
• Brachytherapy: Perspectives for combined treatments with immunotherapy

  2025cites this paper
• Radiotherapy for endometrial cancer: 2025 update.

  2025cites this paper
• Mismatch Repair-Deficient FIGO Stage IA Endometrial Adenocarcinoma With Negative Nodal Biopsy Presenting as Isolated Orbital Metastasis

  2025cites this paper
• Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.

  2024cites this paper
• The Effect of Bladder Volume on Three-dimensional Vaginal Cuff Brachytherapy Planning

  2024cites this paper
• Pivotal Science From the 2022 International Gynecologic Cancer Society Meeting.

  2023cites this paper
• Practice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in China

  2023cites this paper
• Uterine Neoplasms, Version 1.2023

  2023influential citation
• Predictors of recurrence and survival in lymphovascular space invasion negative early-stage endometrioid endometrial cancer patients

  2023cites this paper
• Racial Disparities in Brachytherapy Treatment among Women with Cervical and Endometrial Cancer in the United States

  2023cites this paper
• Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

  2023cites this paper
• Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022–2023 : prise en charge du cancer de l'endomètre localisé

  2023cites this paper
• The Use of 3D Printing Technology in Gynaecological Brachytherapy—A Narrative Review

  2023cites this paper
• Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

  2023cites this paper
• Impact of bowel space contouring variability on radiation dose and volume assessments in treatment planning for gynaecologic cancers

  2023cites this paper
• Impact of external beam pelvic radiotherapy of endometrial carcinoma: A focus on chronic digestive toxicity.

  2022cites this paper
• Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China

  2022cites this paper
• Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists

  2022cites this paper
• Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy

  2022cites this paper
• Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy: The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial.

  2022cites this paper
• Automated causal inference in application to randomized controlled clinical trials

  2022cites this paper
• Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysis

  2021cites this paper
• British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: Recommendations for practice.

  2021cites this paper
• Stage one endometrioid endometrial adenocarcinoma: is there a role of traditional hospital follow-up in the detection of cancer recurrence in women after treatment?

  2021cites this paper
• Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer

  2021cites this paper
• Radiotherapy for endometrial cancer.

  2021cites this paper
• Current treatment modalities in major gynecologic cancers: Emphasis on response rates

  2021cites this paper
• Adjuvant vaginal cuff brachytherapy in surgically treated endometrial carcinoma patients – in view of the recent evidence

  2021cites this paper
• Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy

  2021cites this paper
• Half‐beam volumetric‐modulated arc therapy in adjuvant radiotherapy for gynecological cancers

  2021cites this paper
• Recent Advances in Endometrial Cancer

  2020cites this paper
• Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy

  2020cites this paper
• Simultaneous Integrated Intensity Modulated Radiotherapy Boost for Gynecological Cancer when Brachytherapy is not an Option

  2020cites this paper
• Adjuvant Radiation Therapy in Carcinoma Endometrium: An Update

  2020cites this paper
• Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer

  2020cites this paper
• Health-Related Quality of Life and Patient-Reported Outcomes in Radiation Oncology Clinical Trials

  2020cites this paper
• Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer

  2020cites this paper
• Adjuvant treatment of endometrial cancer today.

  2020cites this paper
• COVID-19 and Gynecological Cancers: A Summary of International Recommendations

  2020cites this paper
• Principles of Radiation Therapy in Older Adults

  2020cites this paper
• Absolute Clinical Radiation Oncology Review

  2019cites this paper
• Gynecologic Cancers

  2019cites this paper
• Subcutaneous Metastasis of Cancer of the Endometrium: Case Report

  2019cites this paper
• Brachytherapy: An overview for clinicians

  2019cites this paper
• Gynecological Cancers

  2019cites this paper
• A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma.

  2019cites this paper
• Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.

  2019cites this paper
• Adjuvant external beam radiation and brachytherapy for vaginal resection margin positive cervical cancer

  2018cites this paper
• Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study

  2018cites this paper
• Adjuvant therapy for high-risk endometrial cancer: recent evidence and future directions

  2018cites this paper
• Total and Peritoneal Mesometrial Resection

  2018cites this paper
• 5 – Adenocarcinoma of the Uterine Corpus

  2018cites this paper
• The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.

  2018cites this paper
• Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?

  2018cites this paper
• Long‐term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery

  2018cites this paper
• Evolution of adjuvant treatment in endometrial cancer—no evidence and new questions?

  2018cites this paper
• Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• Quality of life and oncological outcome in endometrial cancer patients after vaginal brachytherapy: comparison of two dosing schemes

  2018cites this paper
• Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis.

  2017cites this paper
• Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis

  2017cites this paper
• American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.

  2017cites this paper
• Influence of Comorbidity on the Risk of Death: A Single Institution Study of 1132 Women With Early-stage Uterine Cancer

  2017cites this paper
• Patterns of care in women with high-intermediate risk endometrioid adenocarcinoma in the PORTEC-2 era: A SEER database analysis.

  2017cites this paper
• The impact of patient positioning and use of belly board on small bowel toxicity in patients receiving pelvic radiotherapy for gynecological malignancies

  2017cites this paper
• Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High–Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group

  2017cites this paper
• Patterns of adjuvant radiation usage and survival outcomes for stage I endometrial carcinoma in a large hospital-based cohort.

  2017cites this paper
• [Clinical trials and perspectives of radiotherapy for uterine endometrial cancers].

  2017cites this paper
• Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone

  2017cites this paper
• Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer

  2017cites this paper
• Association of Lymph Node Count and Overall Survival in Node-Negative Endometrial Cancers.

  2017cites this paper
• Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study

  2016cites this paper
• Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy

  2016cites this paper
• Rectal contrast increases rectal dose during vaginal cuff brachytherapy.

  2016cites this paper
• Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.

  2016cites this paper
• Adenocarcinoma of the Endometrium — The Art of Its Diagnosis

  2016cites this paper
• Dosimetric benefits of intensity‐modulated radiotherapy and volumetric‐modulated arc therapy in the treatment of postoperative cervical cancer patients

  2016cites this paper
• Refining the Definition of Low-Risk Endometrial Cancer: Improving Value.

  2016cites this paper
• The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care

  2016influential citation
• Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

  2016cites this paper
• Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer

  2015cites this paper
• Radiation Therapy in Gynecologic Cancer

  2015cites this paper
• The effect of lymphadenectomy and radiotherapy on recurrence and survival in endometrial carcinoma. Experience in a population reference centre.

  2015cites this paper
• Chemotherapy for High-Risk Early-Stage Endometrial Cancer: Current Evidence

  2015cites this paper
• Management of Stage I Endometrial Cancer in France: A Survey on Current Practice

  2015cites this paper
• Past, Present and Future Perspectives on the Management of Endometrial Cancer— A Comprehensive Review

  2015cites this paper
• Current Concepts in Radiation Therapy for Early-Stage Endometrial Cancer

  2015cites this paper
• Salvage Versus Adjuvant Radiation Treatment for Women With Early-Stage Endometrial Carcinoma: A Matched Analysis

  2015cites this paper
• The Role of Radiation Therapy in the Treatment of Malignant Gynecological Tumors

  2015cites this paper
• Treatment of Endometrial Cancer

  2015cites this paper
• Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors

  2015cites this paper
• The role of vaginal cuff brachytherapy in endometrial cancer.

  2015cites this paper
• Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria

  2015cites this paper
• ResearchProspective multi-center trial utilizing electronic brachytherapy for the treatment of endometrial cancer

  2015cites this paper
• Effect of race and histology on patterns of failure in women with early stage endometrial cancer treated with high dose rate brachytherapy.

  2015cites this paper
• Impact of post operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: results of the phase II RTCMIENDOMETRE French multicentre trial.

  2014cites this paper
• Critical analysis of cases of endometrial carcinoma of the uterine corpus incidentally diagnosed after incomplete surgery for other indications. Three case reports and a review of the literature

  2014cites this paper
• Postoperative Radiotherapy Alone Versus Chemoradiotherapy in Stage I-II Endometrial Carcinoma: An Investigational and Propensity Score Matching Analysis

  2014cites this paper
• A dosimetric analysis of intensity-modulated radiation therapy with bone marrow sparing for cervical cancer.

  2014cites this paper